OGT 2115
CAS No. : 853929-59-6
| Size | Price | Stock |
|---|---|---|
| 5mg | $88 | In-stock |
| 10mg | $154 | In-stock |
| 25mg | $330 | In-stock |
| 50mg | $550 | In-stock |
| 100mg | $880 | In-stock |
| 200 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-100898 |
| M.Wt: | 495.30 |
| Formula: | C24H16BrFN2O4 |
| Purity: | >98 % |
| Solubility: | DMSO : 11.36 mg/mL (22.94 mM; Need ultrasonic) |
OGT 2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC50 of 0.4 μM. OGT 2115 has anti-angiogenic properties (IC50 of 1 μM). OGT 2115 also inhibits heparan sulfate degradation activity[1][2]. IC50 & Target: IC50: 0.4 μM (Heparanase)[1] In Vitro: Heparanase InhibitorOGT 2115 can suppress metastasis induced by endoplasmic reticulum (ER) stress in breast cancer cells, although not significantly. However, compared with the control group, the number and rate of migrated cells are significantly reduced following the exposure of the cells to Tunicamycin + OGT 2115. OGT 2115 significantly inhibits the invasion and migration induced by Adriamycin. Furthermore, the MTT assay results show that OGT 2115 does not decrease the anti-proliferative effect of Adriamycin[2]. In Vivo: When administered to mice, OGT 2115 (Compound 12d) shows a plasma concentration of ~10x the heparanase IC50 following oral dosing at 20 mg/kg[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information- Product Name:
- OGT 2115
- Cat. No.:
- HY-100898
- Quantity:
Your information is safe with us.